USPTO serial 79431770
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Glycoproteins; Protein in raw material form for scientific and medical research; Recombinant nucleic acid, other than for medical or veterinary purposes; enzymes for industrial use; enzymes for scientific use; Enzymes for scientific and research purposes, other than for medical use for marking protein fractions; enzymes derived from biotechnological processes for industrial use; Enzymes for use in protein hydrolysis; Cell culture media for the biotechnology industry, other than for medical or veterinary purposes; Nucleoproteins, other than for medical or veterinary purposes; Biochemical products, namely, precursors for in-vitro genetic engineering; biochemical products, namely, monoclonal antibodies for in vitro scientific research use; Biochemical preparations for in-vitro and in-vivo scientific use; Biochemical preparations, other than for medical or veterinary purposes; Plant extracts, other than essential oils, for use in the manufacture of cosmetics; Proteins for use in the manufacture of food; Protein in raw material form for manufacturing food for humans; Raw proteins for scientific and medical research; raw proteins for use in industry; proteins for use in industry; Proteins for use in manufacture of cosmetic products; proteins for the food industry; Proteins for use in the manufacture of food supplements; Proteins for recombinant DNA techniques, other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary use. | ACTIVE | — |
| 005 | Human immunoglobulin for medical use; Biotechnological preparations for medical use, namely, antibodies, recombinant proteins, and complex peptides for diagnostics and treatment of cancer and other human diseases; Sanitary products, namely, formulation preparations for medical use for medicine; Pharmaceutical products for the prevention, diagnostics, and treatment of cancer and other human diseases; Veterinary products, namely, recombinant proteins, vaccines, and biologic therapeutics for veterinary use; food supplements; disinfectants; fungicides. | ACTIVE | — |
| 042 | Scientific research; Technological research in the field of industrial biotechnology and biopharmaceuticals; Engineering services, namely, technical testing in the field of industrial biotechnology and biopharmaceuticals; Computer software development; Computer software design; research and development of new products for third parties; Scientific and technological research services, namely, conducting of technical project studies in the field of industrial biotechnology and biopharmaceuticals; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; Software as a service (SaaS) service featuring software for managing, optimizing and monitoring recombinant protein production workflows in microalgae, including digital tracking of strains, culture conditions, expression data and analyses in the field of biotechnology; Providing technology information in the field of industrial biotechnology and biopharmaceuticals; Design and development of operating software for accessing and using a cloud computing network. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 24, 2026 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 24, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| May 26, 2026 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 26, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 30, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 11, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 11, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |